Testing Efficacy of an Intervention to Promote Resilience in Stroke Survivor-carepartner Dyads (ReStoreD)

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Affecting nearly 800,000 people in the US every year, stroke is a leading cause of long-term disability, and has serious consequences for stroke survivors and their carepartners. Our project uses a scientifically rigorous efficacy study to evaluate a remotely delivered 8-week dyadic (couples-based) positive psychology intervention to reduce emotional distress in stroke survivors and their carepartners. If successful, couples may be better emotionally equipped to cope with the sequelae of stroke, and have better rehabilitation outcomes and quality of life.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Community-dwelling cohabitating couple where one partner has a had an ischemic or hemorrhagic stroke

• The stroke must have occurred between 3 months and 3 years prior to enrollment

• The adult couple must have been living together since before the stroke and for at least 6 months prior to enrollment

• One or both partners must report some anxiety and/or depressive symptoms

• Participants must be able to read, understand, and follow instructions, and be able to provide their own consent

Locations
United States
Utah
University of Utah
RECRUITING
Salt Lake City
Contact Information
Primary
Alexandra L Terrill, PhD
alex.terrill@hsc.utah.edu
8015815951
Backup
Lorie Richards, PhD, OTR/L
lorie.richards@hsc.utah.edu
8015851069
Time Frame
Start Date: 2022-07-20
Estimated Completion Date: 2027-08-31
Participants
Target number of participants: 400
Treatments
Experimental: ReStoreD
8-week intervention that is remotely delivered, consisting of psychoeducation and positive psychology activities. Participants complete two activities individually and two together each week.
No_intervention: Waitlist-control
Participants will be waitlisted for 8 weeks.
Related Therapeutic Areas
Sponsors
Leads: University of Utah

This content was sourced from clinicaltrials.gov